Rahmi Gabriel, Tanaka Shinwa, Ohara Yoshiko, Ishida Tsukasa, Yoshizaki Tetsuya, Morita Yoshinori, Toyonaga Takashi, Azuma Takeshi
Department of Hepatogastroenterology and Digestive Endoscopy, Université Paris Descartes, Georges Pompidou European Hospital, Paris, France.
J Dig Dis. 2015 Jan;16(1):14-21. doi: 10.1111/1751-2980.12207.
Superficial colorectal tumors can be treated effectively by endoscopic submucosal dissection (ESD). Few data are available on using ESD for residual or recurrent tumors after the first endoscopic resection. This study aimed to evaluate the efficacy of ESD for these lesions.
In all, 28 patients with residual or recurrent superficial colorectal tumors were referred to the Kobe University Hospital for ESD. The therapeutic outcomes and the possible factors predictive of procedure difficulties for ESD were analyzed.
In total, 27 (96.4%) patients were successfully treated using ESD. There was no related immediate complication. One patient had a delayed perforation which was then treated surgically. En bloc R0 resection was possible in all the patients and curative resection in 26 patients (92.9%). One invasive cancer was treated surgically. More than one previous endoscopic resection was the only significant predictive factor for the difficulty in performing ESD. None of the patients experienced recurrence during a follow-up of 22 months (range 3-41 months).
The use of ESD allowed a high rate of en bloc resection for residual or locally recurrent colorectal tumors. Furthermore, these lesions should be treated by ESD as a first-line treatment.
内镜黏膜下剥离术(ESD)可有效治疗结直肠表浅肿瘤。关于ESD用于首次内镜切除术后残留或复发性肿瘤的数据较少。本研究旨在评估ESD治疗这些病变的疗效。
共有28例结直肠表浅肿瘤残留或复发患者被转诊至神户大学医院接受ESD治疗。分析了治疗结果以及ESD手术困难的可能预测因素。
共有27例(96.4%)患者通过ESD成功治疗。无相关即刻并发症。1例患者发生迟发性穿孔,随后接受手术治疗。所有患者均可行整块R0切除,26例(92.9%)可行根治性切除。1例浸润性癌接受了手术治疗。既往内镜切除次数超过1次是ESD手术困难的唯一显著预测因素。在22个月(范围3 - 41个月)的随访中,无患者出现复发。
ESD可实现结直肠残留或局部复发性肿瘤的高整块切除率。此外,这些病变应将ESD作为一线治疗方法。